410 related articles for article (PubMed ID: 19212436)
1. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells.
Alghisi GC; Ponsonnet L; Rüegg C
PLoS One; 2009; 4(2):e4449. PubMed ID: 19212436
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial-cadherin stimulates syndecan-1-coupled insulin-like growth factor-1 receptor and cross-talk between αVβ3 integrin and vascular endothelial growth factor receptor 2 at the onset of endothelial cell dissemination during angiogenesis.
Rapraeger AC; Ell BJ; Roy M; Li X; Morrison OR; Thomas GM; Beauvais DM
FEBS J; 2013 May; 280(10):2194-206. PubMed ID: 23331867
[TBL] [Abstract][Full Text] [Related]
3. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
Adam AP; Sharenko AL; Pumiglia K; Vincent PA
J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167
[TBL] [Abstract][Full Text] [Related]
4. Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway.
Oliveira-Ferrer L; Hauschild J; Fiedler W; Bokemeyer C; Nippgen J; Celik I; Schuch G
J Exp Clin Cancer Res; 2008 Dec; 27(1):86. PubMed ID: 19114005
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of major integrin α
McDonnell CJ; Garciarena CD; Watkin RL; McHale TM; McLoughlin A; Claes J; Verhamme P; Cummins PM; Kerrigan SW
J Thromb Haemost; 2016 Dec; 14(12):2536-2547. PubMed ID: 27606892
[TBL] [Abstract][Full Text] [Related]
6. Vitronectin increases vascular permeability by promoting VE-cadherin internalization at cell junctions.
Li R; Ren M; Chen N; Luo M; Zhang Z; Wu J
PLoS One; 2012; 7(5):e37195. PubMed ID: 22606350
[TBL] [Abstract][Full Text] [Related]
7. Talin-Dependent Integrin Activation Regulates VE-Cadherin Localization and Endothelial Cell Barrier Function.
Pulous FE; Grimsley-Myers CM; Kansal S; Kowalczyk AP; Petrich BG
Circ Res; 2019 Mar; 124(6):891-903. PubMed ID: 30707047
[TBL] [Abstract][Full Text] [Related]
8. Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation.
Lee CS; Kim YG; Cho HJ; Park J; Jeong H; Lee SE; Lee SP; Kang HJ; Kim HS
Sci Rep; 2016 Jul; 6():29393. PubMed ID: 27381080
[TBL] [Abstract][Full Text] [Related]
9. Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.
Leblond P; Dewitte A; Le Tinier F; Bal-Mahieu C; Baroncini M; Sarrazin T; Lartigau E; Lansiaux A; Meignan S
Anticancer Drugs; 2013 Sep; 24(8):818-25. PubMed ID: 23728220
[TBL] [Abstract][Full Text] [Related]
10. Integrin alpha v beta 3 antagonist Cilengitide enhances efficacy of radiotherapy in endothelial cell and non-small-cell lung cancer models.
Albert JM; Cao C; Geng L; Leavitt L; Hallahan DE; Lu B
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1536-43. PubMed ID: 16863930
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation of vascular endothelial cadherin and the regulation of microvascular permeability.
Nwariaku FE; Liu Z; Zhu X; Turnage RH; Sarosi GA; Terada LS
Surgery; 2002 Aug; 132(2):180-5. PubMed ID: 12219009
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase.
Xu M; Waters CL; Hu C; Wysolmerski RB; Vincent PA; Minnear FL
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1309-18. PubMed ID: 17670896
[TBL] [Abstract][Full Text] [Related]
13. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
14. Targeting β1-integrin inhibits vascular leakage in endotoxemia.
Hakanpaa L; Kiss EA; Jacquemet G; Miinalainen I; Lerche M; Guzmán C; Mervaala E; Eklund L; Ivaska J; Saharinen P
Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6467-E6476. PubMed ID: 29941602
[TBL] [Abstract][Full Text] [Related]
15. Dynamic Regulation of Vascular Permeability by Vascular Endothelial Cadherin-Mediated Endothelial Cell-Cell Junctions.
Rho SS; Ando K; Fukuhara S
J Nippon Med Sch; 2017; 84(4):148-159. PubMed ID: 28978894
[TBL] [Abstract][Full Text] [Related]
16. Integrins regulate VE-cadherin and catenins: dependence of this regulation on Src, but not on Ras.
Wang Y; Jin G; Miao H; Li JY; Usami S; Chien S
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1774-9. PubMed ID: 16446427
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
Lin MT; Yen ML; Lin CY; Kuo ML
Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
[TBL] [Abstract][Full Text] [Related]
18. Pyk2 phosphorylation of VE-PTP downstream of STIM1-induced Ca
Soni D; Regmi SC; Wang DM; DebRoy A; Zhao YY; Vogel SM; Malik AB; Tiruppathi C
Am J Physiol Lung Cell Mol Physiol; 2017 Jun; 312(6):L1003-L1017. PubMed ID: 28385807
[TBL] [Abstract][Full Text] [Related]
19. Matrix stiffness regulates vascular integrity through focal adhesion kinase activity.
Wang W; Lollis EM; Bordeleau F; Reinhart-King CA
FASEB J; 2019 Jan; 33(1):1199-1208. PubMed ID: 30102569
[TBL] [Abstract][Full Text] [Related]
20. Angiopoietin-1 protects heart against ischemia/reperfusion injury through VE-cadherin dephosphorylation and myocardiac integrin-β1/ERK/caspase-9 phosphorylation cascade.
Lee SW; Won JY; Lee HY; Lee HJ; Youn SW; Lee JY; Cho CH; Cho HJ; Oh S; Chae IH; Kim HS
Mol Med; 2011; 17(9-10):1095-106. PubMed ID: 21738954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
